Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Randomized Controlled Trial

NCT01718951 is registered in ClinicalTrials.gov with Tuen Mun Hospital as lead sponsor.

NCT NCT01718951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01718951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Randomized Controlled Trial
Lead sponsor
Tuen Mun Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2012
Completion date
October 31, 2014
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spondyloarthropathy